Despite investigations suggesting that DBF4 can promote hepatocellular carcinoma (HCC) progression by activating STAT317, considering the complex physiological functions of DBF4 and its potential impacts on various signaling pathways, the precise mechanisms through which DBF4 promotes HCC still warrant further investigation. This evidence concerns the gene DBF4 and hepatocellular carcinoma.